Weight Loss. Weight Loss. Don’t Tell Me.
There are new ways to tackle weight loss, but the stocks leading the way are lagging. Today on Motley Fool Money, Rick Munarriz, with analysts Karl Thiel and Jason Hall dig into the problems with weight loss stocks. There’s also a look at some investments that can survive next month’s potential volatility as well as a…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Motley Fool Hidden Gems Investing
See all episodes →Similar episodes from other shows
More like Motley Fool Hidden Gems Investing →
Alphabet Reports Results… And Pharma Stocks Diverge In Weight Loss Drug Race 2/4/26
Here's How the New Weight Loss Drugs Could Change Everything
MM #274: Stocks That Benefit From Trump, Nvidia’s Top Risk, Ozempic $2B Lawsuits, & September Market Strategy
#211 The Weight Loss Drug Revolution: The Hottest Trend on Wall Street
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.